What is Kodiak Sciences Inc's preferred stock?

Kodiak Sciences Inc (KOD) reported preferred stock of $0 in Q1 2026.

What does preferred stock mean?

Equity securities with priority over common stock for dividends and liquidation proceeds, but typically without voting rights.

Kodiak Sciences Inc KOD Preferred Stock

Preferred Stock at other companies

Ultragenyx PharmaceuticalRARE

$0—

Relay Therapeutics, Inc.RLAY

$0—

PVL

Palvella TherapeuticsPVLA

$0—

Kymera TherapeuticsKYMR

$0—

BioCryst PharmaceuticalsBCRX

$0—

Nektar TherapeuticsNKTR

$0—

Other financials

Income statement

See full

Operating income-$59.8M-1.2%

Net income-$58.2M-1.2%

EPS (diluted)-$0.94+13.8%

Balance sheet

See full

Cash & equivalents$169.5M+22.1%

Total debt$56.0M-17.2%

Total equity$112.1M+3.0%

Total assets$306.0M+2.7%

Cash flow

See full

Operating cash flow-$40.0M-37.6%

CapEx$942.0K+249%

Free cash flow-$41.0M-39.5%

Valuation

See full

Market cap$2.32B+1,477%

Enterprise value$2.2B+2,798%

Returns & leverage

See full

Return on equity-208.8%+2,306pp

Debt / equity0.5×-0.1×

Current ratio3.5×-1.1×

Where this comes from

Reported directly by Kodiak Sciences Inc in its filing.

Tagged under the XBRL concept us-gaap:PreferredStockValue.

The official record: Kodiak Sciences Inc’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Kodiak Sciences Inc's preferred stock.

Connect your AI assistant and see it in context, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Kodiak Sciences Inc's preferred stock?: Kodiak Sciences Inc (KOD) reported preferred stock of $0 in Q1 2026.
What does preferred stock mean?: Equity securities with priority over common stock for dividends and liquidation proceeds, but typically without voting rights.